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Adipose tissue-derived mesenchymal stem cells (ASC) are of great interest as a cellu-
lar therapeutic agent for regenerative and immunomodulatory purposes. The function of
ASC adapts to environmental conditions, such as oxygen tension. Oxygen levels within
tissues are typically much lower than under standard culture conditions and ASC used for
therapy therefore encounter a change from normoxic to hypoxic conditions. The effect of
hypoxia on the regenerative potential of ASC has been investigated in a number of stud-
ies.The effect of hypoxia on the immunomodulatory function of ASC, however, remains to
be determined. In the present study the effect of hypoxic (1% oxygen) culture conditions
on human ASC was examined. ASC showed no signs of toxicity under low oxygen levels
and no major immunophenotypical changes were observed, apart from a down regula-
tion of the marker CD105. Oxygen tension had no effect on the proliferation of ASC and
colony forming unit efficiency remained the same under 1 and 20% oxygen. Under both
oxygen levels ASC were capable of strong upregulation of the immunomodulatory mole-
cules indoleamine 2,3-dioxygenase (IDO) and programed death ligand-1 upon stimulation
with IFN-γ and TNF-α, and, in addition, IDO activity as measured by the accumulation of
L-kynurenine was not affected under hypoxia. The ability of ASC to inhibit anti-CD3/CD28
stimulated CD4+ and CD8+ T cell proliferation was not hampered by hypoxia. The results
of the present study demonstrate that the immunosuppressive capacity of ASC is main-
tained under hypoxic conditions. These findings are important for the therapeutic use of
ASC and may be applied for the in vitro generation of ASC with improved functionality for
therapeutic use.
Keywords: mesenchymal stem cells, cell therapy, hypoxia, immune modulation, oxygen level
INTRODUCTION
Mesenchymal stem cells (MSC) have emerged as cells with great
clinical potential. In vitro studies have demonstrated the immuno-
suppressive and regenerative capacities of MSC. Currently, MSC
have been evaluated as a cell therapeutic agent in many medical
fields including graft versus host disease, solid organ transplan-
tation, and Crohn’s disease (1–3). MSC can be isolated from a
wide range of tissues (4, 5), of which bone marrow is the classical,
and most frequently used source. However, bone marrow aspira-
tion is invasive and is accompanied with donor morbidity (6). In
contrast, adipose tissue is more accessible, has a higher yield of
MSC, and adipose tissue-derived mesenchymal stem cells (ASC)
share many properties with their bone marrow derived counter-
parts (7, 8). Adipose tissue is therefore the favored source of MSC
in an increasing number of studies (9–11). To obtain sufficient
numbers of MSC for research and certainly clinical application
the cells are culture expanded. Culture conditions, however, have
striking effects on the phenotype and function of MSC. Advantage
of this can be taken by modulating culture conditions in such a
way that cells with superior functionality are obtained.
Oxygen concentration is an important environmental factor
that affects MSC. While MSC are normally cultured under 20%
oxygen tension, tissue-resident MSC face much lower oxygen
concentrations. Oxygen tension in adipose tissue, for instance,
fluctuates depending on blood flow, but varies typically between 3
and 11% (12). Lower oxygen concentrations can occur in the inci-
dence of injury. It has been demonstrated that hypoxic conditions
affect the function of bone marrow derived MSC. Culturing under
1% oxygen reduces MSC senescence while it increases proliferation
and maintains the differentiation properties of the cells (13). Simi-
lar results have been obtained for MSC derived from adipose tissue
and Wharton’s jelly (14–16). This suggests that MSC are triggered
by injury-induced hypoxic conditions to expand and eventually
differentiate. MSC have also been shown to enhance their angio-
genic potential under hypoxia by increasing their secretion of
vascular endothelial growth factor (VEGF) and bFGF (17).
Tissue trauma is almost without exception followed by
inflammation. Inflammation in its turn is a major activator of
the immunosuppressive capacity of MSC (18), which thereby
allows regeneration by inhibiting immune activity. It is however
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unknown whether hypoxia, occurring before the initiation of
inflammation, alters the immunosuppressive capacities of MSC.
As these capacities are essential for MSC therapy, it is important to
evaluate the effect of hypoxia on MSC. Therefore, in the present
study we examined the effect of low oxygen concentrations on the
phenotype and immunomodulatory properties of human ASC.
MATERIALS AND METHODS
ADIPOSE TISSUE
Subcutaneous adipose tissue was surgically removed from healthy
live kidney donors during the kidney donation procedure after
written informed consent, as approved by the Medical Ethi-
cal Committee of the Erasmus MC (protocol no. MEC-2006-
190). Adipose tissue was collected in essential medium alpha
(MEM-α) (Life Technologies, Paisley, UK) supplemented with
100 U/ml penicillin and 10,000 U/ml streptomycin (p/s) and 2 mM
l-glutamine (Lonza, Verviers, Belgium).
ASC ISOLATION
Adipose tissue-derived mesenchymal stem cells were isolated from
adipose tissue of five donors as described previously (5, 19).
In brief, adipose tissue was mechanically disrupted, enzymati-
cally digested with sterile 0.5 mg/ml collagenase type IV (Sigma-
Aldrich, St. Louis, MO, USA) in RPMI-1640+ glutaMAX (Life
Technologies) and p/s for 30 min at 37°C. Cells were resuspended
in ASC culture medium, consisting of MEM-α with 15% fetal
bovine serum (FBS) (Lonza), transferred to a 175 cm2 culture
flask (Greiner Bio-one, Essen, Germany), and kept at 37°C, 5%
CO2, 20% O2, and 95% humidity. Medium was changed every
3–4 days. When>90% confluent, ASC were detached using 0.05%
trypsin-EDTA at 37°C and either directly used for experiments
or frozen until usage. ASC were used for experiments between
passages 1 and 5.
IMMUNOPHENOTYPING BY FLOW CYTOMETRY
Adipose tissue-derived mesenchymal stem cells were immunophe-
notyped by flow cytometry after standard culture expansion and
after 1 week exposure to hypoxic culture conditions. Subconflu-
ent ASC were trypsinized and washed with FACSFlow (BD Bio-
sciences, San Jose, CA, USA). Cell suspensions were incubated
with mouse-anti-human monoclonal antibodies against CD45-
PerCP,CD73-PE,CD166-PE,HLA-ABC-APC,HLA-DR-APC-Cy7
(all BD Biosciences), and CD105-FITC (R&D Systems, Abingdon,
UK) at room temperature in the absence of light for 15 min.
After two washes with FACSFlow, flow cytometric analysis was
performed using an eight color FACSCANTO-II with FACSDIVA
Software (BD Biosciences) and FlowJo Software (Tree Star, Palo
Alto, CA, USA).
HYPOXIC CULTURE CONDITIONS
Hypoxic conditions were induced by culture of ASC in 1% O2, 5%
CO2, and 94% N2 in a 95% humidified atmosphere. Control cells
were kept under normoxic conditions (20% O2).
LACTATE MEASUREMENTS
Adipose tissue-derived mesenchymal stem cells were seeded in
six-well plates at a concentration of 200,000 cells per well in ASC
culture medium and kept under either normoxic or hypoxic con-
ditions. After 3 days, the conditioned medium was collected and
frozen at −80°C until usage. A lactate assay kit (BioVision, Mil-
pitas, CA, USA) was used for measurement of lactate levels. In
brief, samples were incubated with 50µl of the Reaction Mix for
30 min at room temperature in the dark. The formed product was
measured spectrophotometrically at 570 nm on a Victor2 1420
multilabel plate reader (PerkinElmer, Santa Clara, MA, USA) and
corrected for background.
MEASUREMENT OF METABOLIC ACTIVITY BY MTT ASSAY
Adipose tissue-derived mesenchymal stem cells were seeded in
96-well flat bottom plates at a concentration of 3000 cells per
well in 200µl ASC culture medium and kept for 24, 48, or 72 h
under normoxic or hypoxic conditions. Five hours prior to the
end of the incubation, 20µl sterile MTT (Sigma-Aldrich) (5 mg
MTT/ml dissolved in 1× PBS) was added to the wells. Culture
medium was then removed and 100µl DMSO added to the cells to
dissolve formed crystals. Mitochondrial conversion of MTT was
determined by absorbance measurements at 550 nm wavelength
on a Victor2 1420 multilabel plate reader.
COLONY FORMING UNIT ASSAY
Adipose tissue-derived mesenchymal stem cells were seeded at 50
cells per 6 cm diameter culture dishes in quintuple (3.0 cells/cm2).
After 2 weeks of culture under normoxic or hypoxic conditions,
medium was removed, the dishes washed with PBS, and fixed
in 70% ethanol. Colonies were stained with 2.3% crystal violet
solution (Sigma-Aldrich) for 30 min. Dishes were then washed
with tap water and colonies with a diameter of more than 1 mM
counted. Colony forming unit (CFU) efficiency was expressed as
the percentage of cells capable of forming colonies.
PROLIFERATION ASSAY
Adipose tissue-derived mesenchymal stem cells were seeded at a
density of 1000 cells/cm2 in 75 cm2 culture flasks and kept under
normoxic or hypoxic conditions for 1 week without medium
changes. Cells were then detached by trypsinization, counted, and
re-seeded. Population doublings were calculated using the formula
2log (number of cells at t d7/number of cells at t d0). Cumulative
population doublings during five consecutive weeks of culture
were plotted.
QUANTITATIVE mRNA EXPRESSION
Adipose tissue-derived mesenchymal stem cells were seeded in six-
well plates at a concentration of 1× 105 per well in the presence
or absence of 20 ng/ml TNFα and 50 ng/ml IFNγ and kept under
normoxic or hypoxic conditions. After 6, 24, or 72 h, RNAlater
(Life Technologies) was added to the cells. RNA was isolated and
500 ng used for cDNA synthesis as described previously (20). Gene
expression was determined by real-time RT-PCR using univer-
sal PCR master mix (Life Technologies) and Assays-on-demand
for hypoxia induced factor 1α (HIF1-α) (Hs00153153.m1), HIF2-
α (Hs1026149.m1), VEGF (Hs00173626.m1), indoleamine 2,3-
dioxygenase (IDO) (Hs00158627.m1), PDL-1 (Hs00204257.m1),
TGFβ1 (Hs00171257.m1), IL10 (Hs00174086.m1), IL6 (Hs00
174131.m1), and CXCL10 (Hs00171042.m1) (all Applied Bio-
sciences, Foster City, CA, USA) on an ABI PRISM 7700 sequence
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detector (Applied Biosystems). As housekeeping gene expression
fluctuates under hypoxia, data was expressed as relative copy num-
ber of the PCR products per 500 ng RNA. Relative copy number
was calculated using the formula 2(40-Ct value).
IDO ACTIVITY MEASUREMENTS
Adipose tissue-derived mesenchymal stem cells were cultured for
24 or 72 h with or without 20 ng/ml TNF-α and 50 ng/ml IFN-γ
under normoxic or hypoxic conditions. The tryptophan metabolic
activity of IDO was determined by measurement of l-kynurenine
in the conditioned medium of five ASC cultures. Thirty percent
of trichloroacetic acid was added to the samples at a 1:3 ratio
and after 30 min incubation at 50°C the samples were centrifuged
at 12,000 rpm for 5 min. Supernatants were then diluted 1:1 in
Ehrlich reagent [200 mg 4-dimethylaminobenzaldehyde (Sigma,
St. Louis, MO, USA) in 10 ml of glacial acetic acid] in duplicate
in a 96-wells flat bottom plate and absorbance was determined
at 490 nm using a multilabel plate reader (VersaMax™, Mole-
cular Devices, Sunnyvale, CA, USA). l-Kynurenine (Sigma, St.
Louis, MO, USA) diluted in unconditioned medium was used as
standard.
PBMC ISOLATION
Peripheral Blood Mononuclear Cells (PBMC) were collected from
buffy coats of healthy blood bank donors. PBMC were isolated by
density gradient centrifugation using Ficoll Isopaque (δ= 1.077,
Amersham, Uppsala, Sweden) and frozen−135°C until use.
ANTI-CD3/CD28 LYMPHOCYTE STIMULATION ASSAY
Peripheral blood mononuclear cells were labeled using the PKH26
Red Fluorescent Cell Linker Kit (Sigma-Aldrich) and stimu-
lated with anti-CD3 antibody (0.5µl/5× 105 cells), anti-CD28
antibody (0.5µl/5× 105 cells), and a goat-anti-mouse antibody
(1µl/5× 105 cells) for cross-linking (all BD Biosciences). PBMC
were seeded in round-bottom 96-well plates at 5× 104 cells per
well and ASC added at 1:2.5, 1:5, 1:10, and 1:20 ratios in MEM-α
with p/s and 10% heat inactivated (HI)-human serum. After 3 days
of incubation under normoxic or hypoxic conditions, PBMC
were collected, washed twice with FACSFlow (BD Biosciences),
and incubated with monoclonal antibodies against TCR-FITC
(Serotec, Oxford, UK), CD3-AmCyan, CD4-Pacific Blue, CD8-
PerCP (all BD Biosciences) for 15 min at room temperature in the
absence of light. After two washes with FACSFlow, flow cytometric
analysis was performed using an eight color FACSCANTO-II with
FACSDIVA Software (BD Biosciences).
STATISTICAL ANALYSIS
Data were statistically analyzed using Mann Whitney,and Kruskal–
Wallis statistical tests. p< 0.05 was considered significant.
RESULTS
ASC IDENTITY
In several previous studies we have demonstrated that the adher-
ent cells of the stromal vascular fraction of human adipose tis-
sue are ASC with properties similar to bone marrow MSC (5,
19, 21). Thus ASC have a spindle-shaped fibroblastic morphol-
ogy in culture, have a CD45−CD73+CD105+CD166+HLAclass
I+ immunophenotype and can differentiate in adipogenic and
osteogenic lineages (19) (data not shown).
CULTURE OF ASC UNDER HYPOXIC CONDITIONS
Under hypoxic conditions, cells are forced to switch to anaerobic
metabolism and will produce lactate. In our model, ASC signif-
icantly increased lactate concentrations in the culture medium
after 3 days of culture under hypoxic conditions (28.3 mM, range
25–31 versus 12 mM, range 10–14, under normoxic conditions)
(Figure 1A). Culture of ASC under hypoxic conditions (1% O2)
for 24 h had no effect on mRNA expression levels of hypoxia-
inducible factor 1-α (HIF1-α) and HIF2-α (Figure 1B). As hypoxia
stabilizes HIF protein, we examined whether gene expression
FIGURE 1 | (A) Lactate production by ASC. ASC were cultured under 20 or
1% O2 for 3 days and medium collected for lactate measurements. Mean
with SEM of three experiments is shown. (B) Effect of hypoxia on gene
expression of hypoxia-inducible genes; mRNA expression of HIF1-α and
HIF2-α by ASC after 24 h culture under normoxic (20% O2) and hypoxic (1%
O2) conditions. Mean with SD of four different experiments is shown. (C)
mRNA expression of VEGF, downstream of HIF1-α under normoxia and
hypoxia. Mean with SD of four different ASC cultures, *Indicates p<0.05.
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downstream of HIF was affected by hypoxia in ASC. Expression
of VEGF downstream of HIF1-α was significantly increased under
hypoxia by nearly a factor two (Figure 1C).
EFFECT OF HYPOXIA ON ASC CHARACTERISTICS
To study the effect of hypoxia on ASC characteristics, meta-
bolic activity, survival, growth, and proliferation of ASC was
examined. Culture of ASC under 1% O2 for 24 h up to 72 h
had no effect on ASC metabolic activity and there was no evi-
dence for loss of cell viability, as measured by the mitochondrial
reduction of MTT to formazan (Figure 2A). There was a sim-
ilar increase in the conversion of MTT under normoxic and
hypoxic conditions at 24 h up to 72 h, which reflects the simi-
lar increase in cellular metabolic activity under both conditions.
Parallel culture of ASC under normoxic and hypoxic conditions
for five consecutive weeks demonstrated no difference in popula-
tion doubling times, which were 2.6 days (range 1.9–3.1), under
normoxia and 2.5 days (range 1.9–5.0) under hypoxia. There-
fore, cumulative population doublings were the same under both
oxygen tensions (Figure 2B). Furthermore, there was no differ-
ence in the CFU capacity of ASC cultured under 20 and 1%
O2 (Figure 2C), suggesting oxygen tension does not affect the
stemness of ASC. Finally, the immunophenotype of ASC was deter-
mined after 10 days of culture under normoxic or hypoxic condi-
tions. Under both conditions, the ASC immunophenotype was
CD45−CD73+CD105+CD166+HLA-I+HLA-II− (Figure 2D).
The expression of CD105 was, however, significantly lower in
ASC cultured under hypoxic conditions (MFI 2530) than in ASC
cultured under normoxia (MFI 4215).
EFFECT OF HYPOXIA ON THE EXPRESSION OF IMMUNOMODULATORY
GENES BY ASC AND IDO ACTIVITY
It is known that the immunomodulatory capacity of ASC is
induced under inflammatory conditions. This was confirmed in
the present study by showing that treatment of ASC with IFN-
γ and TNF-α for 6, 24, and 72 h induced a strong increase in
the mRNA expression of immunomodulatory programed death
ligand-1 (PD-L1) (102-fold), CXCL10 (106-fold), and IDO (105-
fold). Under hypoxic conditions, ASC maintained the capacity to
induce the expression of IDO, PD-L1, and CXCL10 in response
to IFN-γ and TNF-α to a similar extent as under normoxic
concentrations (Figures 3A–C).
To determine whether hypoxia affected the tryptophan deplet-
ing activity of IDO in ASC we measured concentrations of
l-kynurenine, the breakdown product of tryptophan, in condi-
tioned medium of ASC cultured for 24 or 72 h with or without
TNF-α and IFN-γ under 20 or 1% oxygen. Culture with TNF-
α and IFN-γ strongly increased l-kynurenine levels at 24 and
72 h (Figures 3D,E). Hypoxia did not affect l-kynurenine levels
indicating preserved IDO activity under hypoxic conditions.
Furthermore, TGF-β, associated with the immunomodulatory
capacity of ASC, was expressed by ASC under resting conditions
and at similar levels upon stimulation with IFN-γ and TNF-α.
Hypoxia did not affect TGF-β expression (data not shown). IL10
was not expressed by ASC under any of the conditions tested (data
not shown). Pro-inflammatory IL6 was expressed by ASC, and
its expression did not change under low oxygen conditions (data
FIGURE 2 | Effect of hypoxia on ASC characteristics. (A) ASC metabolic
activity measured by MTT assay. Mean with SEM of three different ASC
cultures shown. (B) Cumulative population doublings of ASC cultured under
normoxic and hypoxic conditions. (C) CFU efficiency of ASC. Mean with
SEM of four different ASC cultures shown. (D) Immunophenotype of ASC
after culturing for 10 days under normoxic and hypoxic conditions. Filled
histogram; unstained ASC, solid line; ASC cultured under 20% O2, dotted
line; ASC cultured under 1% O2. *Indicates p<0.05.
not shown). These data suggest that ASC maintain their capacity
to express immunomodulatory factors and respond to inflamma-
tory conditions by activating their immunomodulatory apparatus
under hypoxic conditions.
IMMUNOSUPPRESSIVE CAPACITIES OF ASC UNDER HYPOXIA
To study whether hypoxia influences the in vitro immunosup-
pressive capacities of ASC, ASC were added to anti-CD3 and
anti-CD28 stimulated PKH-labeled allogeneic PBMC. The pro-
liferation of CD4+ and CD8+ T cells tended to be lower under
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FIGURE 3 | Effect of hypoxia on the induction of PD-L1 (A), CXCL-10
(B), and IDO (C); mRNA expression in ASC after IFN-γ/TNF-α
stimulation. ASC were cultured under 20 or 1% O2 for 6, 24, or 72 h with
or without 50 ng/ml IFN-γ and 20 ng/ml TNF-α. Every data point represents
a distinct ASC culture (n=4 different ASC cultures). (D,E) IDO activity
determined by accumulation of L-kynurenine in ASC conditioned medium
in the absence and presence of TNF and IFN [24 h (D) and 72 h (E)]. Means
of five ASC cultures with SEM shown.
hypoxia than under normoxia, although the difference was not
significant. Under normoxia, there was a significant inhibition of
CD4+ and CD8+ T cell proliferation at ASC: PBMC ratios of
1:2.5 (Figures 4A,B). Under hypoxia, inhibition of T cell prolifer-
ation was more profound as T cell proliferation was significantly
inhibited till ASC:PBMC ratios up to 1:5 (Figures 4A,B). Direct
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FIGURE 4 | (A–D) PBMC were labeled with PKH and stimulated with
anti-CD3/CD28 antibodies. On day 3, the proliferation of CD4+ and CD8+ T
cells was analyzed by flow cytometry. (A,B) percentage proliferating cells
shown. (C,D) percentage inhibition of proliferation shown, compared to the
condition without ASC. Mean with SEM of three experiments with different
ASC cultures shown, *p-value<0.05.
comparison of the T cell inhibition by ASC under normoxia and
hypoxia demonstrated that inhibition of CD4+ and CD8+ T cell
proliferation was significantly higher at a 1:5 under 1% oxygen
level (Figures 4C,D).
DISCUSSION
Adipose tissue-derived mesenchymal stem cells possess an assort-
ment of properties that make them suitable for regenerative
and immunomodulatory applications. The properties of ASC are
affected by changing environmental conditions that induce ASC to
adapt a particular function. Oxygen tension is one of these envi-
ronmental factors. Oxygen tension in tissue fluctuates between
3 and 11% (22) and may be lower in case of trauma, and such
changes may affect the function of ASC. In the present study, we
cultured ASC under 20 and 1% oxygen to examine whether oxygen
tension would affect the in vitro properties of ASC.
In the present study we found that ASC were resistant to hypoxic
conditions and detected no signs of toxicity or decreased CFU
efficiency under low oxygen concentrations. There is some con-
troversy on the effect of hypoxia on the proliferation of bone
marrow and ASC, with some studies reporting an inhibitory effect
of low oxygen levels on proliferation (23–25), others reporting
increased proliferation (26), while we found that ASC prolifera-
tion was not affected over at least five passages. There are a number
of factors that may influence the outcome of studies, such as the
percentage of oxygen used to generate hypoxic conditions with
some studies using 1% oxygen and others up to 5%. Further-
more, the composition of the cell culture medium, in particular
the use of serum, and the species of ASC used will affect out-
comes. In the present study, the immunophenotype of ASC was
only moderately affected by hypoxia, which is in line with ear-
lier studies (24, 25). In our hands, only the expression of CD105
(endoglin) was consistently down regulated under low oxygen
tension. This is quite surprisingly, as CD105 is known to be up
regulated under hypoxia in endothelial cells (27). The conse-
quence of the down regulation of CD105, which is an adhesive
molecule, and part of the TGFβ receptor complex remains to be
determined.
In the current study, we further found that a hypoxic pre-
conditioning regimen does not hamper the immunosuppressive
properties of ASC. The immunosuppressive function of ASC is
induced by inflammatory cytokines such as IFN-γ and TNF-α (18,
28). These cytokines stimulate the expression of anti-proliferative
IDO and of the inhibitory co-stimulatory molecule PD-L1. The
induction of these proteins and the activity of IDO were not
affected by hypoxic conditions, indicating that the immunosup-
pressive machinery of ASC is maintained at low oxygen con-
centrations. In addition, the strongly enhanced expression of
the chemokine CXCL10 under inflammatory conditions was not
affected by hypoxia, suggesting that the chemoattractive prop-
erties of ASC for immune cells are preserved under low oxygen
concentrations.
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Subsequently, we found that culture under 1% O2 did not hin-
der the suppressive effects of ASC on T cell proliferation. The
percentage of inhibition of T cells by ASC was even increased under
hypoxia. Thus although ASC under hypoxia were phenotypically
indifferent from ASC under normoxic conditions, they had a more
profound effect on T cell proliferation. One explanation could be
that hypoxic conditions shift the balance between T cell prolif-
eration and the inhibitory effect of ASC. Thus while T cells are
affected in their proliferation by hypoxia, as demonstrated earlier
(29) and shown in the present study, ASC maintain their suppres-
sive capacity. It is possible that under hypoxic conditions,T cells are
more sensitive to low tryptophan concentrations induced by IDO
expression in ASC or by PD-L1 induced inhibition of prolifera-
tion. ASC therefore have a relatively larger impact on inflammatory
conditions and are more effective in inhibiting immune responses
under hypoxic conditions, such as in case of trauma, than under
normoxic conditions. Alternatively, the enhanced efficacy of ASC
to inhibit T cell proliferation under hypoxia may be explained by
the fact that ASC employ additional mechanisms of immunomod-
ulation under hypoxic conditions that were not analyzed in the
present study.
In summary, our data indicates that a reduction of oxygen
tension up to at least 1% does not hamper the immunomod-
ulatory therapeutic efficiency of ASC. This is of relevance
as for most clinical purposes, the immunosuppressive capaci-
ties of ASC are essential. Assertion of these capacities under
hypoxia is crucial as ASC will encounter hypoxic conditions
when administered for most, if not all, immunomodulatory
applications. Subsequently, as there is evidence that hypoxic
pre-conditioning enhances the regenerative potential of ASC
(17, 30), maintenance of immunosuppressive capacities under
hypoxia is needed when hypoxia pre-conditioning will be used
for regenerative application. The present study shows that in
these situations, the immunomodulatory capacity of ASC is
preserved.
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